Healthcare
Live Price
Offline$53.50
+0.00% today
1Y Change
+86.80%
Window
Jun 30, 2025 โ Jun 26, 2026
Coverage: 255 bars ยท Jun 30, 2025 โ Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Haw Par Corporation Limited (HAWPY) is a Healthcare stock with a market cap of $3.81B and listed on OTC. The stock last traded around $53.50 and up 86.8% across the available one-year price window (Jun 30, 2025 โ Jun 26, 2026). Baseline metrics include revenue growth of -7.6%, EPS growth of +14.6%, a dividend yield of 8.1%. What stands out right now is revenue -7.6%, EPS +14.6%, free cash flow +426.3% with operating margin 29.2% and ROIC 1.5%. The dividend matters to the case here, with a current yield around 8.1%. Valuation already assumes a fairly strong business story at P/E 14.4 and price/sales 16.6. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines HAWPY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
HAWPY is 68.81 pts ahead over the shared 1Y window.
HAWPY had 5.65 pts shallower max drawdown than SPY.
HAWPY beat SPY in 1 of 2 calendar years shown and trailed in 1.
HAWPY
+86.80%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
+68.81 pts
Relative to SPY
HAWPY Max Drawdown
-3.48%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for HAWPY and SPY.
| Year | HAWPY | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | +5.31% | +6.71% | -1.39 pts | SPY |
| 2025 | +77.37% | +11.19% | +66.18 pts | HAWPY |
Unable to load analyst forecasts.
Timed out loading forecasts for HAWPY
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.